• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Glycerol ethers

Introduction to 2-methoxy-3-(octadecyloxy)propan-1-ol (CAS No. 84337-43-9)

2-methoxy-3-(octadecyloxy)propan-1-ol, identified by its Chemical Abstracts Service (CAS) number 84337-43-9, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, featuring a unique structural motif comprising an octadecyl chain and methoxy substituent, exhibits promising properties that make it a valuable candidate for various applications, particularly in drug delivery systems and bioactive molecule synthesis.

The molecular structure of 2-methoxy-3-(octadecyloxy)propan-1-ol consists of a propan-1-ol backbone, which is modified by the introduction of a methoxy group at the second carbon position and an octadecyloxy group at the third carbon position. This bifunctional design imparts distinct physicochemical characteristics, including high lipophilicity and solubility in both organic and aqueous media, which are critical for formulating novel therapeutics. The presence of the long hydrocarbon chain enhances membrane permeability, making this compound an attractive candidate for topical and transdermal drug delivery applications.

In recent years, the pharmaceutical industry has seen a surge in the development of targeted therapies that leverage advanced chemical entities to improve drug efficacy and reduce side effects. 2-methoxy-3-(octadecyloxy)propan-1-ol has been explored as a key intermediate in synthesizing prodrugs designed to enhance bioavailability and controlled release profiles. Its ability to undergo selective enzymatic or chemical degradation at specific sites allows for precise modulation of drug release kinetics, which is particularly relevant in oncology and chronic disease management.

One of the most compelling aspects of 2-methoxy-3-(octadecyloxy)propan-1-ol is its potential role in enhancing the solubility of poorly water-soluble drugs. By serving as a solubilizing agent or co-solvent, this compound can significantly improve the pharmacokinetic properties of active pharmaceutical ingredients (APIs), thereby increasing their therapeutic index. This approach has been successfully applied in clinical trials for drugs that suffer from low solubility issues, demonstrating the compound's versatility in pharmaceutical formulations.

Moreover, research into 2-methoxy-3-(octadecyloxy)propan-1-ol has extended to its applications in polymer chemistry and material science. The compound's unique structural features enable it to act as a monomer or crosslinking agent in polymer synthesis, leading to the development of novel biodegradable polymers with enhanced mechanical and thermal properties. These materials have potential uses in biomedical implants, wound healing dressings, and controlled-release matrices for sustained drug delivery.

The synthesis of 2-methoxy-3-(octadecyloxy)propan-1-ol involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to construct the desired molecular framework efficiently. These synthetic strategies not only highlight the compound's complexity but also underscore the importance of innovative chemical techniques in producing high-value intermediates for pharmaceutical applications.

Recent studies have also explored the biological activity of derivatives of 2-methoxy-3-(octadecyloxy)propan-1-ol, revealing potential therapeutic benefits in areas such as anti-inflammatory and anti-tumor research. The octadecyl moiety, in particular, has been shown to interact with biological membranes in a manner that can modulate cell signaling pathways. This interaction has sparked interest in developing novel small molecules that leverage similar structural motifs to target specific disease mechanisms.

The commercial significance of 2-methoxy-3-(octadecyloxy)propan-1-ol is further emphasized by its growing demand from research institutions and pharmaceutical companies worldwide. As drug discovery efforts continue to evolve, compounds like this one that offer multifunctional properties are becoming increasingly indispensable tools for medicinal chemists and biologists. The ability to customize both hydrophilic and hydrophobic regions within a single molecule allows for unparalleled flexibility in designing next-generation therapeutics.

In conclusion, 2-methoxy-3-(octadecyloxy)propan-1-ol (CAS No. 84337-43-9) represents a fascinating example of how structural innovation can lead to functional breakthroughs across multiple scientific disciplines. Its unique combination of lipophilicity, solubility, and biocompatibility positions it as a cornerstone compound in modern drug development. As research progresses, it is anticipated that new applications for this versatile molecule will continue to emerge, further solidifying its role as a critical component in advancing therapeutic solutions.

• 41107-82-8(2,5-Anhydro-D-mannitol)
• 5306-85-4(Isosorbide dimethyl ether)
• 652-67-5(Isosorbide)
• 27826-73-9(2,5-Anhydro-D-glucitol)
• 544-62-7(Batyl alcohol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)